Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jul 19, 2017, 03:00 ET Alzheimer's Association Launches $20 Million Lifestyle Intervention Trial In The U.S. To Prevent Cognitive Decline

– Results from 4,000 Participants re: Impact of Brain Amyloid Imaging on Medical Management – – Possible Blood Test for Amyloid – The...


Jul 19, 2017, 03:00 ET La Asociación del Alzheimer en EE.UU. lanza un estudio de 20 millones de dólares para prevenir el deterioro cognitivo

– Resultados de 4.000 participantes, ref.: Impacto de los biomarcadores con amiloide en imágenes cerebrales en la gestión médica – Posible prueba...


Jul 19, 2017, 03:00 ET L'Alzheimer's Association lance une étude d'intervention sur le mode de vie de 20 millions USD aux États-Unis dans le but d'éviter le déclin cognitif

– Résultats de 4000 participants concernant : l'impact de l'imagerie amyloïde cérébrale sur la prise en charge médicale – – Une analyse sanguine...


Jul 19, 2017, 03:00 ET Alzheimer's Association startet in den USA großangelegte Interventionsstudie mit 20 Millionen USD-Volumen, um dem Abbau von kognitiven Fähigkeiten präventiv durch geänderte Lebensführung entgegenzuwirken

– Ergebnisse von 4.000 Teilnehmern zeigen auf, wie sich Amyloid-Bildgebung des Gehirns auf patientenbezogene Behandlungspläne auswirkt – –...


Jul 18, 2017, 17:45 ET Alpha Tau Medical Secures Second Funding Round to Treat Solid Tumors With Alpha Radiation

Alpha Tau Medical Ltd. has raised 20% more capital than planned for its Alpha DaRT cancer treatment. The funding will be used to further develop...


Jul 18, 2017, 14:02 ET Otwarty proces recenzji i porecenzyjny: nowe kryteria publikacji naukowych w przyszłości

OMICS International dąży do osiągnięcia niespotykanego wzrostu w publikacjach otwartego dostępu Otwarty proces recenzji, towarzyszący...


Jul 18, 2017, 13:51 ET Partnering Cells Turn Off Immune Attack on Pancreatic Tumors

Two cell types work together to protect pancreatic tumors from destruction by the immune system. But, blocking this partnership may restore the...


Jul 18, 2017, 10:43 ET Dostupné vzájemné hodnocení a následné vzájemné hodnocení: vznikající kritéria budoucího vědeckého publikování

Společnost OMICS International usiluje o bezprecedentní růst v publikování s otevřeným přístupem Otevřený systém vzájemného hodnocení je...


Jul 18, 2017, 10:36 ET Открытое экспертное рецензирование и постоценка: новые критерии для будущих научных публикаций

OMICS International стремится к беспрецедентному росту в сфере открытой издательской деятельности Система открытого экспертного...


Jul 18, 2017, 10:33 ET SeraCare Life Sciences Announces the Most Patient-Like cfDNA QC Technology

SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, is launching the...


Jul 18, 2017, 10:22 ET Offene Begutachtung und nachträgliche Begutachtung: die entstehenden Kriterien bei künftigen wissenschaftlichen Veröffentlichungen

OMICS International auf dem Weg zu beispiellosem Wachstum bei offen zugänglichen Veröffentlichungen Offene Begutachtungssysteme werden von...


Jul 18, 2017, 09:58 ET L'examen ouvert par comité de lecture et l'examen par des pairs en aval: les nouveaux critères de l'édition scientifique de demain

OMICS International vise une croissance sans précédent dans l'édition en accès ouvert Le système ouvert d'examen par un comité de lecture a...


Jul 18, 2017, 08:50 ET Oramed Appoints Dr. Simon Bruce as Vice President of Medical Affairs

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a developer of oral drug delivery systems, announced today the appointment of Dr....


Jul 18, 2017, 08:36 ET Kitov Announces Results of Study Demonstrating NT-219 Enhanced Efficacy of Keytruda® in Immune-Oncology Preclinical Model

Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV) (TASE: KTOV), an innovative biopharmaceutical company, today announced results of a...


Jul 18, 2017, 08:31 ET TrialScope Expands Commitment to Patients; Adds Support for Seven Additional Languages to Trial Results Summaries Portal

TrialScope, the global leader in patient-centric clinical trial transparency and compliance solutions, today announced that the Trial Results...


Jul 18, 2017, 08:31 ET TrialScope erweitert Engagement für Patienten; Trial Results Summaries Portal-Support wird um sieben zusätzliche Sprachen ergänzt

Marktführer für patientenorientierte Transparenz baut Zugang zu Studienergebnissen für Teilnehmer, Patienten und Öffentlichkeit aus Wie...


Jul 18, 2017, 08:31 ET TrialScope expande su compromiso con pacientes y soporta siete idiomas en el portal de resúmenes de resultados de ensayos

Este líder en soluciones transparentes centradas en el paciente expande el acceso a la información de resultados de los ensayos clínicos para los...


Jul 18, 2017, 08:31 ET TrialScope élargit son engagement envers les patients ; il ajoute une assistance en sept autres langues à son Trial Results Summaries Portal

Le chef de file mondial en matière de solutions de transparence axées sur les patients élargit l'accès à l'information sur les résultats d'essais...


Jul 18, 2017, 08:30 ET Sociedade Brasileira de Reumatologia (SBR) emite recomendações atualizadas de tratamento para Artrite Reumatoide

- Brasil conta com as mais avançadas terapias para tratamento de Artrite Reumatoide (AR), doença crônica, autoimune e que pode levar à...


Jul 18, 2017, 08:30 ET DelMar Pharmaceuticals Announces Completion of First Site Initiation Visit for STAR-3 Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM

DelMar Pharmaceuticals (Nasdaq: DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on the development of new cancer therapies,...


Jul 18, 2017, 08:02 ET Provention Bio, Inc. Announces Clinical Program Focused on Intercepting and Preventing the Onset of Type 1 Diabetes

Provention Bio, Inc., a clinical stage biopharmaceutical company dedicated to sourcing, developing and commercializing novel therapeutics aimed at...


Jul 18, 2017, 08:00 ET Capricor Receives Rare Pediatric Disease Designation from FDA for CAP-1002 for Patients with Duchenne Muscular Dystrophy

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing biological therapies for Duchenne muscular dystrophy and other rare...


Jul 18, 2017, 08:00 ET Aldeyra Therapeutics Announces Last Patient Dosed in Dry Eye Disease Phase 2a Clinical Trial

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a clinical-stage biotechnology company devoted to treating inflammation, inborn errors of...


Jul 18, 2017, 08:00 ET Nektar Announces Topline Data from Human Abuse Potential Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain

Nektar Therapeutics (NASDAQ: NKTR) announced positive topline results from an oral Human Abuse Potential (HAP) study of NKTR-181, a first-in-class...


Jul 18, 2017, 07:30 ET Avant Diagnostics Highlights Published Clinical Utility Data for Theralink® mTOR Pathway Activation Data Predicting Tamoxifen® and Other Endocrine Treatment Response in Estrogen Receptor Positive (ER+) Breast Cancer

- Two thirds of all breast cancer (BC) tumors are estrogen receptor positive (ER)+ - ER+ BC patients have mixed responses to...